Back to Search Start Over

Discovery of a Potent, S1P3-Sparing Benzothiazole Agonist of Sphingosine-1-Phosphate Receptor 1 (S1P1).

Authors :
Lanman BA
Cee VJ
Cheruku SR
Frohn M
Golden J
Lin J
Lobera M
Marantz Y
Muller KM
Neira SC
Pickrell AJ
Rivenzon-Segal D
Schutz N
Sharadendu A
Yu X
Zhang Z
Buys J
Fiorino M
Gore A
Horner M
Itano A
McElvain M
Middleton S
Schrag M
Vargas HM
Xu H
Xu Y
Zhang X
Siu J
Bürli RW
Source :
ACS medicinal chemistry letters [ACS Med Chem Lett] 2010 Nov 09; Vol. 2 (2), pp. 102-6. Date of Electronic Publication: 2010 Nov 09 (Print Publication: 2011).
Publication Year :
2010

Abstract

Optimization of a benzofuranyl S1P1 agonist lead compound (3) led to the discovery of 1-(3-fluoro-4-(5-(2-fluorobenzyl)benzo[d]thiazol-2-yl)benzyl)azetidine-3-carboxylic acid (14), a potent S1P1 agonist with minimal activity at S1P3. Dosed orally at 0.3 mg/kg, 14 significantly reduced blood lymphocyte counts 24 h postdose and attenuated a delayed type hypersensitivity (DTH) response to antigen challenge.

Details

Language :
English
ISSN :
1948-5875
Volume :
2
Issue :
2
Database :
MEDLINE
Journal :
ACS medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
24900287
Full Text :
https://doi.org/10.1021/ml100228m